Acasti Pharma
225 Promenade du Centropolis
Suite 200
Laval
Quebec
H7T 3B3
Canada
Tel: 450-687-2262
Fax: 450-687-2272
126 articles with Acasti Pharma
-
Acasti Pharma to Showcase at the Cambridge Healthtech Institute and the BioPharmaceutical Strategy Series
4/14/2010
-
Acasti Pharma to Present at the ATVB 2010 Council of the American Heart Association
4/8/2010
-
Neptune Technologies & Bioressources Inc. is Granted Method of Use Patent for Cardiovascular Disease Applications in Europe; EFSA Stamps Final Approval for NKO(R) NOVEL FOOD and PARNUTS Status
10/29/2009
-
Acasti Pharma Completes Offer to Exchange Outstanding Neptune Technologies & Bioressources Inc. Dividend Notes
10/21/2008
-
Neptune Technologies & Bioressources Inc. Successfully Completes $2.75 Million Private Placement with 10% Management Participation
10/9/2008
-
Neptune Technologies & Bioressources Inc. Further Advances Its Cardiovascular Pharmaceutical Development Through Its New Operating Subsidiary Acasti Pharma
8/22/2008